DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Gradishar WJ, Krasnojon D, Cheporov S. et al.
Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer.
J Clin Oncol 2009;
27: 3611-3619
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.